Skip to main content
Journal ArticleOPEN ACCESS

Aripiprazole versus ziprasidone for schizophrenia

Cochrane Database of Systematic Reviews (2017) 2017(9)
DOI: 10.1002/14651858.CD012811
0Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the clinical efficacy and safety of aripiprazole versus ziprasidone for the treatment of people with schizophrenia.

Cite

CITATION STYLE

APA

Yang, H. L., Zheng, J. G., Li, B., Zhao, S., & Zheng, W. (2017). Aripiprazole versus ziprasidone for schizophrenia. Cochrane Database of Systematic Reviews, 2017(9). https://doi.org/10.1002/14651858.CD012811

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free